Ear Nose & Throat Journal · 2012 · 10 citations · 7 references
MedicineOncologyOtolaryngologyLaryngologyOtolaryngologic SurgeryThoracic OncologyLaryngeal CancerLymphoid NeoplasmsLymphoid TumorsNatural Killer Cell BiologyClinical RemissionNatural Killer T-cell LymphomaNatural Killer-cell LymphomaNon-hodgkin Lymphoma TherapyNon-hodgkin Lymphoma Treatment
Laryngeal extranodal non-Hodgkin lymphoma is uncommon, accounting for less than 1% of all laryngeal neoplasms; the B-cell phenotype is predominant. Lymphomas outside the nasal cavity are rare and highly aggressive. We present a case of primary natural killer T-cell (NK/T-cell) lymphoma of the larynx that arose in a 45-year-old man. Because only a limited amount of data is available on laryngeal NK/T-cell lymphoma, the mainstay of treatment remains unclear, although some data suggest that radiotherapy alone is the best option. Our patient was treated with chemotherapy and radiotherapy, and he remained in remission 2 years later.
7
Radiotherapy As Primary Treatment for Stage IE and IIE Nasal Natural Killer/T-Cell Lymphoma
Ye‐Xiong Li, Bo Yao, Jing Jin et al. · Journal of Clinical Oncology · 2005 · 359 citations
Heather A. Anderson, Robert H. Maisel, Robert W. Cantrell · The Laryngoscope · 1976 · 41 citations · Full text